Advances in genetic and genomic technologies over the last thirty years have greatly
enhanced our knowledge concerning the genetic architecture of Alzheimer's disease (AD) …

Dementia is a leading cause of disability and death worldwide. At present there is no
disease modifying treatment for any of the most common types of dementia such as …

There are growing concerns about potential delayed, neuropsychiatric consequences (eg,
cognitive decline, mood or anxiety disorders) of sports-related traumatic brain injury (TBI) …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that currently affects
36 million people worldwide with no effective treatment available. Development of AD …

Abstract See Schmahmann (doi: 10.1093/brain/aww064) for a scientific commentary on this
article. Neurodegenerative diseases are associated with distinct and distributed patterns of …

Traumatic brain injury (TBI) affects an estimated 1.7 million people in the United States and
is a contributing factor to one third of all injury related deaths annually. According to the …

Background Previous research has described distinct subtypes of Alzheimer's disease (AD)
based on the differences in regional patterns of brain atrophy on MRI. We conducted a data …

Objective. The objective of this study was to compare glucose metabolism and atrophy, in
the precuneus and cingulate cortex, in patients with Alzheimer's disease (AD) and mild …

The conceptual significance of understanding functional brain alterations and cognitive
deficits associated with Alzheimer's disease (AD) process has been widely established …

Objective: We examined the utility of distinguishing between patients with frontotemporal
lobar degeneration (FTLD) and Alzheimer disease (AD) using quantitative cerebral blood …